Chemical Compound
Doxorubicin Hydrochloride EP Impurity A; Epirubicin hydrochloride EP Impurity D; (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
CAS Registry Number
20830-81-3
Primary record
Doxorubicin Hydrochloride EP Impurity A; Epirubicin hydrochloride EP Impurity D; (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
- 库存
- 7,192 克
- 纯度
- 98.1 %
- CAS
- 20830-81-3
化合物标识与属性
- CAS
- 20830-81-3
- PubChem CID
- 30323
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
名称与同义词
- daunorubicin
- Daunomycin
- Rubidomycin
- Acetyladriamycin
- Daunorubicine
- Leukaemomycin C
- Cerubidin
- Daunarubicinum
- Daunorrubicina
- Cerubidine
- Daunamycin
- Rubomycin C
- DaunoXome
- Daunorubicinum
- (+)-Daunomycin
- Daunoblastin
- Anthracyline
- Rubomycin
- 20830-81-3
- Anthracycline
- Daunoblastina
- Daunoblastine
- Daunorubicina
- Daunomycine
- Dauno-Rubidomycine
- daunomicina
- Rubomicin
- Ondena
- DaunoXome (TN)
- 4'-Epidaunomycin
- Dauno Rubidomycine
- DAUNORUBICIN HCL
- Daunorubicin (INN)
- Daunorubicin [INN:BAN]
- Daunorubicinum [INN-Latin]
- RCRA waste no. U059
- Daunorubicin (liposomal)
- Daunomycin hydrochloride
- Tocris-1467
- Daunorubicin, Hydrochloride
- Daunorubicin(Daunomycin)
- Rubidomycin hydrochloride
- Daunomycin, hydrochloride
- FI6339
- AC1L1JCP
- RP 13057
- Prestwick3_000487
- RefChem:919679
- DAUNOMYCIN [IARC]
- DAUNORUBICIN [MI]
- ZS7284E0ZP
- C27H29NO10
- CCRIS 914
- DAUNORUBICIN [INN]
- DAUNORUBICIN CITRATE
- DAUNORUBICIN HYDROCHLORIDE
- Doxorubicin EP Impurity A
- DTXSID7022883
- RP 13057 hydrochloride
- CHEMBL178
- D01XWG
- D08UQF
- D0T7QR
- Antibiotic F.I. 1762
- DAUNORUBICIN [HSDB]
- AC1Q29OI
- DAUNOMYCIN DERIVATIVE
- SCHEMBL3041
- DTXCID402883
- DAUNORUBICIN [VANDF]
- EPIRUBICIN IMPURITY D
- FI 6339
- NCI-C04693
- UNII-ZS7284E0ZP
- NSC-82151
- NSC-83142
- BSPBio_000353
- DAUNORUBICIN [MART.]
- CHEBI:41977
- cid_62770
- HSDB 5095
- MLS000069508
- orb611916
- DAUNORUBICIN [WHO-DD]
- RP-13057
- FI-6339
- STQGQHZAVUOBTE-VGBVRHCVSA-N
- BPBio1_000389
- GTPL7063
- orb3029193
- SCHEMBL29354538
- SCHEMBL29996035
- VYXEOS COMPONENT DAUNORUBICIN
- BDBM32017
- EINECS 244-069-7
- ERK5-1I16
- EX-A1337A
- Valrubicin impurity, daunorubicin
- L01DB02
- MFCD00866340
- NSC 82151
- NSC 83142
- VS-103
- Daunomycin;RP 13057;Rubidomycin
- DAUNORUBICIN [ORANGE BOOK]
- GLXC-23059
- HMS2089H04
- HMS2091K06
- Pharmakon1600-01500223
- CID30323
- DRG-0155
- NSC82151
- ZINC3917708
- BRN 1445583
- Tox21_110896
- BBF-01693
- BDBM50368352
- EBC-27278
- GR-318
- HY-13062A
- LMPK13050002
- LS-997
- NCGC00024246-05
- NSC756717
- Tox21_110896_1
- ACN-040064
- AI3-52942
- AN-9539
- CCG-212559
- CS-2004
- DB00694
- J3.149F
- MD32002
- NDC-0082-4155
- NSC-756717
- Antibiotics from Streptomyces coeruleorubidus
- Doxorubicin EP Impurity A (Free Base)
- NCGC00024246-06
- NCGC00024246-07
- NCGC00024246-09
- NCGC00024246-10
- NCGC00024246-12
- NCGC00024246-15
- NCGC00024246-18
- NCGC00025173-01
- SC-18793
- SMR000058559
- NDC 0082-4155
- SBI-0206677.P002
- CAS-20830-81-3
- LS-187381
- 2019B
- AB00514669
- B1099
- 30D813
- C01907
- D07776
- Epirubicin hydrochloride impurity, daunorubicin-
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione
- 15159-EP2270008A1
- 15159-EP2272827A1
- 15159-EP2277565A2
- 15159-EP2277566A2
- 15159-EP2277567A1
- 15159-EP2277568A2
- 15159-EP2277569A2
- 15159-EP2277570A2
- 15159-EP2289892A1
- 15159-EP2292280A1
- 15159-EP2292617A1
- 15159-EP2295416A2
- 15159-EP2295426A1
- 15159-EP2295427A1
- 15159-EP2298748A2
- 15159-EP2298778A1
- 15159-EP2301928A1
- 15159-EP2305642A2
- 15159-EP2305679A1
- 15159-EP2308833A2
- 15159-EP2308861A1
- 15159-EP2311808A1
- 15159-EP2311829A1
- 15159-EP2311842A2
- 15159-EP2316832A1
- 15159-EP2316833A1
- 16803-EP2272832A1
- 16803-EP2277565A2
- 16803-EP2277566A2
- 16803-EP2277567A1
- 16803-EP2277568A2
- 16803-EP2277569A2
- 16803-EP2277570A2
- 16803-EP2280012A2
- 16803-EP2281815A1
- 16803-EP2286812A1
- 16803-EP2292280A1
- 16803-EP2292615A1
- 16803-EP2298768A1
- 16803-EP2301928A1
- 16803-EP2301933A1
- 16803-EP2305640A2
- 16803-EP2305671A1
- 16803-EP2311825A1
- 16803-EP2311827A1
- 16803-EP2311840A1
- 16803-EP2316937A1
- AB00514669-09
- AB01644616_09
- AB01644616_10
- EN300-7479232
- A814957
- Q411659
- SR-01000000033
- SR-05000001600
- 5,12-Naphthacenedione,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
- SR-01000000033-4
- SR-05000001600-1
- SR-05000001600-2
- BRD-K43389675-001-01-3
- BRD-K43389675-001-02-1
- BRD-K43389675-003-02-7
- BRD-K43389675-003-03-5
- BRD-K43389675-003-16-7
- BRD-K43389675-003-20-9
- (8S,10S)-8-acetyl-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
- DM1
- EPIRUBICIN HYDROCHLORIDE IMPURITY D [EP IMPURITY]
- VALRUBICIN IMPURITY, DAUNORUBICIN [USP IMPURITY]
- 2-HYDROXY-5-(4-NITRO-PHENYLSULFAMOYL)-BENZOICACID
- DOXORUBICIN HYDROCHLORIDE IMPURITY A [EP IMPURITY]
- (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-
- (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
- (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
- EPIRUBICIN HYDROCHLORIDE IMPURITY, DAUNORUBICIN- [USP IMPURITY]
- (1S,3S)-3-ACETYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSIDE
- (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-&alpha
- (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside
- (2S)-1,2,3,4-Tetrahydro-4alpha-(3-amino-2,3,6-trideoxy-alpha-L-galactopyranosyloxy)-2beta-acetyl-2,5,12-trihydroxy-7-methoxynaphthacene-6,11-dione
- (7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-4-methoxy-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- (7S,9S)-9-acetyl-7-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- (7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- (8S)-1-Methoxy-6,8,11-trihydroxy-8beta-acetyl-10alpha-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-5,7,8,9,10,12-hexahydronaphthacene-5,12-dione
- (8S)-10alpha-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1-methoxy-6,8alpha,11-trihydroxy-8beta-acetyl-5,12-naphthacenedione
- (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
- (8S,10S)-8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-6,8,11-TRIHYDROXY-1-METHOXY-7,8,9,10-TETRAHYDROTETRACENE-5,12-DIONE
- (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
- (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
- (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
- (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
- (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-n aphthacenedione
- 244-069-7
- 4alpha-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-2alpha,5,12-trihydroxy-2-acetyl-7-methoxy-1,2,3,4,6,11-hexahydronaphthacene-6,11-dione
- 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL))OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S-CIS)-
- 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
- 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
- 73610-99-8
- DM
- Doxorubicin Hydrochloride EP Impurity A; Epirubicin hydrochloride EP Impurity D; (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
- L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-